3-48862652-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM1PM2BP4
The NM_000387.6(SLC25A20):c.425C>G(p.Ala142Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,608,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A142V) has been classified as Uncertain significance.
Frequency
Consequence
NM_000387.6 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000197  AC: 3AN: 152176Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.00000796  AC: 2AN: 251378 AF XY:  0.00   show subpopulations 
GnomAD4 exome  AF:  0.0000185  AC: 27AN: 1456582Hom.:  0  Cov.: 29 AF XY:  0.0000138  AC XY: 10AN XY: 725002 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000197  AC: 3AN: 152176Hom.:  0  Cov.: 32 AF XY:  0.0000404  AC XY: 3AN XY: 74340 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Carnitine acylcarnitine translocase deficiency    Uncertain:2 
This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 142 of the SLC25A20 protein (p.Ala142Gly). This variant is present in population databases (rs759262977, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with SLC25A20-related conditions. ClinVar contains an entry for this variant (Variation ID: 587448). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Inborn genetic diseases    Uncertain:1 
The c.425C>G (p.A142G) alteration is located in exon 5 (coding exon 5) of the SLC25A20 gene. This alteration results from a C to G substitution at nucleotide position 425, causing the alanine (A) at amino acid position 142 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at